United States: At The Intersection Of Securities Fraud And Public Corruption: The Prosecution Of Representative Christopher Collins

On August 8, 2018, Christopher Collins, a member of the US House of Representatives for New York's 27th congressional district, was arrested on insider trading charges for disseminating material, nonpublic information about the Australian biotechnology company, Innate Immunotherapeutics Limited (Innate). Collins was a member of Innate's Board of Directors and one of the company's largest shareholders. The indictment alleges that, as a member of the Board, Collins was given advance notice of the negative results of a clinical trial for the company's only pipeline drug, which was being developed to treat Secondary Progressive Multiple Sclerosis. 

Specifically, four days before public disclosure of the news, Innate's CEO emailed the Board of Directors to say that the trial was a "clinical failure." The grand jury indictment alleges that within seconds of responding to the CEO's email, Collins called his son, Cameron Collins (who was also charged), six times before he finally picked up the seventh call. On that call, Collins allegedly shared the information about the clinical trial with his son, so that Cameron Collins could sell his stake in Innate. Over the next four days, Cameron Collins and others sold their shares in Innate before the results of the clinical trial were publically announced. Soon after the results were publicized, Innate's stock plummeted by more than 90 percent. By trading on his father's tip, Cameron Collins allegedly avoided approximately $570,900 in losses.

The indictment does not allege that Collins himself personally traded on the information. Instead, federal prosecutors alleged that Collins violated US securities laws, and breached fiduciary duties he owed to Innate, by sharing the material nonpublic information with others with the expectation that they would trade on that information. Collins was allegedly precluded from trading his own shares because they were held in Australia and, at the time, subject to an Australian trading halt.  Interestingly, when Collins received the news about the clinical trial, he was already under investigation by the House Committee on Ethics for his holdings in, and promotion of, Innate. The Office of Congressional Ethics later reported that it found "substantial reason to believe" that Collins violated federal law by meeting with individuals in his congressional capacity in an effort to benefit Innate. The Office also found that Collins shared nonpublic information with lawmakers and others in an attempt to solicit investors. 

The facts of this case, as alleged, appear to be straightforward and consistent with a run-of-the-mill insider trading case. Still, the case represents yet another prosecution of a high-profile New York lawmaker. In fact, this indictment in many ways sits at the cross-section of the Southern District's increased focus in recent years on three types of white collar crime: insider trading, healthcare fraud and public corruption. It is the latest in a series of prosecutions that demonstrate the Southern District's growing effort to hold accountable those who take advantage of their influence for improper gain. 

In one corner, there are the well-publicized public corruption cases coming out of Albany. In those cases, lawmakers and political players such as Sheldon Silver, the former New York State Assembly Speaker, Dean Skelos, the former New York State Senate Majority Leader, and Joseph Percoco, a former aide to Governor Andrew Cuomo, were convicted of honest-services fraud. Silver, for example, was found guilty of leveraging the influence of his office to receive kickbacks and bribes through quid pro quo schemes with real estate developers and an asbestos-cancer researcher. United States v. Silver, 15-cr-00093. Among other things, Silver solicited and obtained client referrals worth millions of dollars in exchange for his official acts. On July 27, 2018, Silver was sentenced to seven years in prison.

In the other corner sits a new wave of insider trading prosecutions that the Southern District has brought involving the "political intelligence" industry and well-known hedge funds such as Visium Asset Management and Deerfield Management Company. Just a few months ago, two partners and analysts of Deerfield Management, along with Christopher Worrall, an employee of the Centers for Medicaid & Medicare Services (CMS), and David Blaszczak, a political intelligence consultant and former CMS employee, were convicted after trial of trading on confidential nonpublic government information. United States v. Blaszczak, 17-cr-00357. These convictions stemmed from a scheme to obtain nonpublic material information from CMS about prospective changes to healthcare reimbursement rates. Worrall was charged with providing information about CMS's internal decision-making to his former colleague and friend, Blaszczak. In exchange for consulting fees, Blaszczak conveyed that information to employees at Deerfield Management, who then traded on the information. Deerfield generated millions in profits as a result of these trades. The four defendants are currently awaiting sentencing.

Somewhere in the middle lies the Collins prosecution. Collins, Worrall, and Silver were each charged with improperly taking advantage of their position for their personal benefit. In the honest services context, public officials are charged with violating duties owed to their constituents. In a "classical" insider trading case, a corporate insider is charged with breaching fiduciary duties owed to the corporation and its shareholders by taking advantage of nonpublic material information for the insider's benefit. Christopher Collins appears to have done both. He clearly violated his duties to Innate. And the Office of Congressional Ethics has concluded that he violated his duties as a congressman. Collins is the latest public official to be prosecuted by SDNY for abusing his public position, like Silver and Worral, for his own benefit.

By aggressively prosecuting these cases, the SDNY is sending a clear message that, regardless of their power, those who leverage their influence and commit fraud will be held accountable.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions